ISAAA releases
Top Ten Facts about Biotech/GM Crops in 2013,
a Special Edition of Crop Biotech Update March 5 issue. We encourage
you to translate and/or use the information therein to develop news
articles for publication in tri-media in your own country, with proper
attribution to ISAAA.
FACT # 1. 2013 was the 18th year of successful commercialization of biotech crops.
Biotech crops were first commercialized in 1996. Hectarage of
biotech crops increased every single year between 1996 to 2013, with 12
years of double-digit growth rates, reflecting the confidence and trust
of millions of risk-averse farmers around the world, in both developing
and industrial countries. Remarkably, since the first plantings in 1996,
an unprecedented cumulative hectarage of more than1.5 billion hectares
have been successfully cultivated, an area that is 50% more than the
total land mass of China or the United States.
FACT # 2. Biotech crop hectares increased by more than 100-fold
from 1.7 million hectares in 1996, to over 175 million hectares in 2013.
This makes biotech crops the fastest adopted crop technology in
recent times – the reason – they deliver benefits. In 2013, hectarage of
biotech crops grew by 5 million hectares, at an annual growth rate of
3%. It is important to note that more modest annual gains, and continued
plateauing, are predicted for the next few years due to the already
optimal (between 90% and 100%) adoption rates for the principal biotech
crops, leaving little or no room for expansion.
FACT # 3. Number of countries growing biotech crops and stacked traits.
Of the 27 countries which planted biotech crops in 2013, 19 were
developing and 8 were industrial countries. Stacked traits occupied 47.1
million hectares, or 27%.
FACT # 4. For the second consecutive year, in 2013, developing countries planted more hectares than industrial countries.
Notably, developing countries grew more, 54% (94 million hectares)
of global biotech crops in 2013 than industrial countries at 46% (81
million hectares). Successful public/private partnerships were
established by several countries including Brazil, Bangladesh and
Indonesia.
FACT # 5. Number of farmers growing biotech crops.
In 2013, a record 18 million farmers, up 0.7 million from 2012, grew
biotech crops – remarkably over 90%, or over 16.5 million, were small
resource-poor farmers in developing countries. Farmers are the masters
of risk-aversion and improve productivity through sustainable
intensification (confining cultivation to the 1.5 billion hectares of
cropland and thereby saving the forests and biodiversity). In 2013, a
record 7.5 million small farmers in China and another 7.3 million in
India, elected to plant more than 15 million hectares of Bt cotton,
because of the significant benefits it offers. In 2013, almost 400,000
small farmers in the Philippines benefited from biotech maize.
FACT # 6. The top 5 countries planting biotech crops –
deployment of the first drought tolerant maize and stacked HT/IR
soybean.
The US continued to be the lead country with 70.1 million hectares,
with an average ~90% adoption across all crops. Importantly, the first
biotech drought tolerant maize was planted by 2,000 US farmers on 50,000
hectares. Brazil was ranked second, and for the fifth consecutive year,
was the engine of growth globally, increasing its hectarage of biotech
crops more than any other country – an impressive record increase of 3.7
million hectares, up 10% from 2012, reaching 40.3 million hectares.
Brazil also planted the first stacked HT/IR soybean in a record-breaking
2.2 million hectare launch, and its home-grown virus-resistant biotech
bean is ready for commercialization. Argentina retained its third place
with 24.4 million hectares. India, which displaced Canada for the fourth
place had a record 11 million hectares of Bt cotton with an adoption
rate of 95%. Canada was fifth at 10.8 million hectares with decreased
plantings of canola but maintained a high adoption rate of 96%. In 2013,
each of the top 5 countries planted more than 10 million hectares
providing a broad, solid foundation for future growth.
FACT # 7. Status of biotech crops in Africa.
The continent continued to make progress with South Africa
benefiting from biotech crops for more than a decade. Both Burkina Faso
and Sudan increased their Bt cotton hectarage by an impressive 50% and
300%, respectively, in 2013. Seven countries (Cameroon, Egypt, Ghana,
Kenya, Malawi, Nigeria and Uganda) conducted field trials, the
penultimate step prior to approval for commercialization. Importantly,
the WEMA project is scheduled to deliver the first biotech drought
tolerant maize to Africa in 2017. The lack of appropriate, science-based
and cost/time-effective regulatory systems continues to be the major
constraint to adoption. Responsible, rigorous but not onerous,
regulation is needed, particularly for small and poor developing
countries.
FACT # 8. Status of biotech crops in the EU.
Five EU countries planted a record 148,013 hectares of biotech Bt
maize, up 15% from 2012. Spain led the EU with 136,962 hectares of Bt
maize, up 18% from 2012 with a record 31% adoption rate in 2013.
FACT # 9. Benefits offered by biotech crops.
From 1996 to 2012, biotech crops contributed to Food Security,
Sustainability and the Environment/Climate Change by: increasing crop
production valued at US$116.9 billion; providing a better environment,
by saving 497 million kg a.i. of pesticides; in 2012 alone reducing CO2
emissions by 26.7 billion kg, equivalent to taking 11.8 million cars off
the road for one year; conserving biodiversity by saving 123 million
hectares of land from 1996-2012; and helped alleviate poverty for
>16.5 million small farmers and their families totalling >65
million people, who are some of the poorest people in the world. Biotech
crops are essential but are not a panacea and adherence to good farming
practices such as rotations and resistance management, are a must for
biotech crops as they are for conventional crops.
FACT # 10. Future Prospects.
Cautiously optimistic with more modest annual gains expected due to
the already high rates of adoption (90% or more) in the principal
biotech crops in mature markets in both developing and industrial
countries. Bangladesh, Indonesia and Panama approved biotech crop
planting in 2013 with plans for commercialization in 2014.
